A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Investigate the Efficacy, Safety, and Tolerability of 3 doses of SPK 0602 (pentamycin) Vaginal Tablets vs Placebo (vehicle) in Patients with Symptomatic Vaginitis due to Bacterial Vaginosis, Candidiasis or Trichomoniasis.

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Investigate the Efficacy, Safety, and Tolerability of 3 doses of SPK 0602 (pentamycin) Vaginal Tablets vs Placebo (vehicle) in Patients with Symptomatic Vaginitis due to Bacterial Vaginosis, Candidiasis or Trichomoniasis.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Feb 2013

At a glance

  • Drugs Pentamycin (Primary)
  • Indications Bacterial vaginosis; Candidiasis; Trichomoniasis; Vaginitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Lumavita
  • Most Recent Events

    • 19 Aug 2011 EudraCT2007-007659-15 identified as trial registry record, and multiple details added
    • 19 Aug 2011 Planned number of patients changed to 484.
    • 03 Mar 2010 Status changed from recruiting to completed, as reported in the EudraCT profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top